is a highly fatal disease, researchers noted. Even after successful surgery, only about 12% of patients are alive five years after diagnosis, according to the American Association of Clinical, so new therapies are urgently needed for patients who face this deadly disease,” researcher Dr. Vinod Balachandran, a surgical oncologist with Memorial Sloan Ketteringcells, using 20 unique proteins exclusively present in a patient's tumor.
Researchers also found expanded levels of cancer-fighting immune cells throughout the bodies of those eight patients, results show. An ongoing clinical trial is testing how the autogene cevumeran vaccine works in combination with chemotherapy and the immunotherapy drug atezolizumab, compared against standard chemotherapy, Balachandran said.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: denverwestword - 🏆 315. / 61 Read more »
Source: PsychToday - 🏆 714. / 51 Read more »
Source: Medscape - 🏆 386. / 55 Read more »
Source: mynbc15 - 🏆 262. / 63 Read more »